Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Research Presented at the Annual CMSC Meeting — June 1-4, 2022

Download PDF

Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Multivariate Proteomic MS Disease Activity Test Score Performance Evaluated in an Independent Focal Inflammation Cohort

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Estimation of Disability Status from Blood Serum Protein Concentrations

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Association Between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Accounting for Variance in Brain Atrophy Measurements by Quantifying Image Quality Differences across Longitudinal Imaging Studies

Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022

Download PDF

Analytical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF

Clinical Validation Study Results of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ECTRIMS Meeting Virtual Conference — October 13-15, 2021

Download PDF

Clinical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF

Integrated Analysis of Novel MRI and Blood Serum Biomarkers for the Estimation and Prediction of MS Disease Activity and Progression

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF

Proteomic Serum Biomarker Signatures Associated with Patient Reported Outcomes in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF

Changes in the Detection of Clinically Relevant White Matter Lesions in MS Using FDA-Cleared Automated Software

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF

Development of a Custom Multivariate Proteomic Serum Based Assay for Association with Radiographic and Clinical Endpoints in MS

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

Cross-sectional and longitudinal estimation of radiographic and clinical endpoints to quantify MS disease trajectory with blood serum protein levels.

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

Improving Patient Outcomes through a Comprehensive Care Management Platform Measuring Outcomes and Value: an Integrated, Novel solution for Generating insights in MS (MOVING MS)

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

From proteome to interactome: a mechanistic approach to MS biomarker discovery

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

Improved detection of clinically relevant MRI findings in Multiple Sclerosis radiology reports using FDA-approved quantitative software

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

BrainGraph: A Novel Visualization of MRI Data as a 3D Graph to Reveal Temporal Features of Disease Progression In Patients with Multiple Sclerosis

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

High throughput lesion evaluation and quality control for incorporating quantitative imaging metrics into clinical practice

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF

Multivariate protein biomarker models more accurately predict multiple sclerosis MRI disease activity compared to serum levels of neurofilament light chain alone

Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019

Download PDF

Classification of high versus low annualized relapse rate status in subjects with relapsing-remitting multiple sclerosis using multivariate serum protein biomarker models

Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019

Download PDF

Clinical disease activity status (exacerbation versus quiescence) in subjects with relapsing-remitting multiple sclerosis is accurately classified using multivariate serum protein biomarker models

Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019

Download PDF

Get In Touch

Please reach out and we’ll be in touch soon.

*First Name

*Last Name

*Email Address

*Institution/Clinic/Company Name

*Role

How Can We Help?

*Required field

By submitting your information, you agree to receive emails from Octave and understand that you may opt out of Octave subscriptions at any time.